Products
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.1 | 1.88 |
NAV | ₹31.15 | ₹40.11 |
Fund Started | 04 Dec 2015 | 25 Jun 2018 |
Fund Size | ₹1339.00 Cr | ₹6103.96 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.1
1.88
NAV
₹31.15
₹40.11
Fund Started
04 Dec 2015
25 Jun 2018
Fund Size
₹1339.00 Cr
₹6103.96 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 4.00% | 8.73% |
3 Year | 24.00% | 28.16% |
5 Year | 18.97% | 21.17% |
1 Year
4.00%
8.73%
3 Year
24.00%
28.16%
5 Year
18.97%
21.17%
Holding Analysis
Equity | 93.81% | 95.89% |
Cash | 6.19% | 4.11% |
Equity
93.81%
95.89%
Cash
6.19%
4.11%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.92% |
Cipla Ltd. | 6.62% |
Apollo Hospitals Enterprise Ltd. | 5.20% |
Lupin Ltd. | 4.77% |
Healthcare Global Enterprises Ltd. | 4.38% |
Torrent Pharmaceuticals Ltd. | 4.32% |
Aster DM Healthcare Ltd. | 4.32% |
Fortis Healthcare Ltd. | 4.00% |
Alkem Laboratories Ltd. | 4.00% |
Max Healthcare Institute Ltd. | 3.80% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.69% |
Dr. Reddy's Laboratories Ltd. | 8.85% |
Divi's Laboratories Ltd. | 8.13% |
Cipla Ltd. | 7.54% |
Aurobindo Pharma Ltd. | 5.71% |
Lupin Ltd. | 5.11% |
Mankind Pharma Ltd. | 3.88% |
Alkem Laboratories Ltd. | 3.83% |
Biocon Ltd. | 3.64% |
Gland Pharma Ltd. | 3.20% |
Fund Manager
Name | Meeta Shetty | Dharmesh Kakkad |
Start Date | 09 Nov 2018 | 23 Feb 2021 |
Name
Meeta Shetty
Dharmesh Kakkad
Start Date
09 Nov 2018
23 Feb 2021
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 04 Dec 2015 | 25 Jun 2018 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Dec 2015
25 Jun 2018
